<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02867917</url>
  </required_header>
  <id_info>
    <org_study_id>2016.360</org_study_id>
    <nct_id>NCT02867917</nct_id>
  </id_info>
  <brief_title>Comparison of Taste and Palatability in Fiber Supplements</brief_title>
  <official_title>Comparison of Taste and Texture of Metamucil, Volcolon and Psyllium Orange Generic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VU University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Teva Pharmaceuticals USA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>VU University Medical Center</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare 1. taste and 2. texture/palatability of Metamucil&#xD;
      orange®, Volcolon® and generic orange psyllium.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background of the study:&#xD;
&#xD;
      A pleasant taste of a prescription improves patient compliance and adherence. According to&#xD;
      the literature, only 50% of patients who suffer from chronic diseases adhere to treatment&#xD;
      recommendations (1). This results in suboptimal outcomes (2). There are numerous factors that&#xD;
      affect adherence, including characteristics of the illness, interaction between physician and&#xD;
      patient, the complexity and duration of treatment, side effects of treatment and costs of&#xD;
      treatment (3). Furthermore, medication palatability is also crucial for adherence. Several&#xD;
      studies have addressed the palatability of medication for different disorders, like&#xD;
      hypertension, HIV and Alzheimer's disease (4-6). Therefore, pharmaceutical companies pay&#xD;
      attention to manufacture more formulations and add pleasant flavours which may improve the&#xD;
      palatability. Fiber supplements are increasingly used for treatment of chronic constipation&#xD;
      both in adults and children. In the Netherlands several formulas are available such as&#xD;
      Metamucil orange®, Volcolon® en generic psyllium orange. These are effective and save&#xD;
      formulas. Little literature is available concerning taste and laxatives or fibers, although&#xD;
      many patients complain about taste and texture of the preparations. Studies with polyethylene&#xD;
      glycol preparations performed by our research group demonstrated some differences in&#xD;
      palatability between these preparations (7-9). There are hardly any studies about fibers and&#xD;
      taste. The taste is mentioned to be acceptable; one study compares dried prunes with psyllium&#xD;
      and concludes there is no difference in taste experience (10). In order to improve patient&#xD;
      compliance, it is of clinical importance to know which preparations are the most acceptable&#xD;
      to the patient, and use that as first choice. We hypothese that the taste and palatability of&#xD;
      Metamucil orange® is preferable.&#xD;
&#xD;
      Objective of the study:&#xD;
&#xD;
      Comparison of 1. taste and 2. texture/palatability of Metamucil orange®, Volcolon® and&#xD;
      generic orange psyllium.&#xD;
&#xD;
      Study design:&#xD;
&#xD;
      It is a double blind, randomized, crossover study.&#xD;
&#xD;
      Study population:&#xD;
&#xD;
      100 healthy volunteers (primary recruitment of medical students).&#xD;
&#xD;
      Intervention: All healthy volunteers will try the 3 different formulas. After swallowing the&#xD;
      first formula, the mouth will be rinsed with water. Then the second formula will be tried,&#xD;
      after rinsing the mouth again the third formula will be tried. Every time after tasting a&#xD;
      formula, the questionnaire is filled in, before starting with the next formula. The maximum&#xD;
      intake is 3 x 25 ml (75 ml), this is 37,5% of one dosage advised quantity of fibre. The&#xD;
      sequence in which the formulas are tasted is randomized.&#xD;
&#xD;
      Preparations and dosage&#xD;
&#xD;
      Each sachet needs to be solved in a glass of water. This matches (approximately) 200 ml.&#xD;
      During the study the volunteers will taste 3 x 25 ml of water. This matches 37,5% of one&#xD;
      dosage. The average intake of psyllium fibers is 1-3 sachets a day. Dosage if the different&#xD;
      products:&#xD;
&#xD;
        -  Volcolon sugar free (Dutch name: Volcolcolon suikervrij): 1 sachet contains 4 g powder o&#xD;
           980mg/g psyllium fibers x 4 g per sachet = 3.92 g psyllium fibers/sachet o So 25 ml&#xD;
           contains 0.490 g psyllium fibers&#xD;
&#xD;
        -  Metamucil Orange: 1 sachet contains 3.4 g psyllium fibers o So 25 ml contains 0.425 g&#xD;
           psyllium fibers&#xD;
&#xD;
        -  Psyllium Orange: 1 sachet contains 3.25 g psyllium fibers o So 25 ml contains 0.406 g&#xD;
           psyllium fibers These three products are the most used products for each brand&#xD;
           (Metamucil orange, Volcolon and generic orange). This leads to the greatest coverage of&#xD;
           the three brands in the Netherlands. The volunteers will swallow 25 ml of each product,&#xD;
           three in total. This leads to an intake of 1.32 g (0.490 g + 0.425 g + 0.406= 1.32 g)&#xD;
           psyllium fibers.&#xD;
&#xD;
      According to the Dutch Board of Health (in Dutch: Gezondheidsraad) the average intake of&#xD;
      fibers should be between 30 and 40 g a day. So, the volunteers will swallow approximately 4%&#xD;
      (3.3 - 4.4%) of the advised intake of fibers. Therefore, we do not expect any problems when&#xD;
      the volunteers swallow these products.&#xD;
&#xD;
      Nature and extent of the burden and risks associated with participation, benefit and group&#xD;
      relatedness (if applicable): The maximum intake is 3 x 25 ml (75 ml), this is 37,5% of one&#xD;
      dosage advised quantity of fibre. Therefore, we do not expect any problems when the&#xD;
      volunteers swallow these products.&#xD;
&#xD;
      References:&#xD;
&#xD;
        1. World Health Organisation. Adherence to long term therapies: evidence for action. 2003.&#xD;
&#xD;
        2. Osterberg L, Blaschke T. Adherence to medication 1. N Engl J Med 2005 August&#xD;
           4;353(5):487-97.&#xD;
&#xD;
        3. Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic&#xD;
           treatment: a review of literature 1. J Behav Med 2008 June;31(3):213-24.&#xD;
&#xD;
        4. Van der Linden D, Callens S, Brichard B, Colebunders R. Pediatric HIV: new opportunities&#xD;
           to treat children 1. Expert Opin Pharmacother 2009 August;10(11):1783-91.&#xD;
&#xD;
        5. Meier CM, Simonetti GD, Ghiglia S, Fossali E, Salice P, Limoni C et al. Palatability of&#xD;
           angiotensin II antagonists among nephropathic children 1. Br J Clin Pharmacol 2007&#xD;
           May;63(5):628-31.&#xD;
&#xD;
        6. Yan YD, Woo JS, Kang JH, Yong CS, Choi HG. Preparation and evaluation of taste-masked&#xD;
           donepezil hydrochloride orally disintegrating tablets 1. Biol Pharm Bull&#xD;
           2010;33(8):1364-70.&#xD;
&#xD;
        7. Felt-Bersma R.J., Kooyman G., Kuipers E.J. Colonic lavage prior to colonoscopy:&#xD;
           comparable outcomes of two polyethylene-glycol preparations and a sodium-phosphate&#xD;
           solution. Ned Tijdschr Geneeskd. 2004 Jan 24; 148 (4): 181-5&#xD;
&#xD;
        8. Szojda MM, Mulder CJ, Felt-Bersma RJ. Differences in taste between two polyethylene&#xD;
           glycol preparations.J Gastrointestin Liver Dis. 2007;16(4):379-81&#xD;
&#xD;
        9. Lam TJ, Mulder CJ, Felt-Bersma RJ. Differences in taste between three polyethylene&#xD;
           glycol preparations: a randomized double-blind study. Patient Prefer Adherence.&#xD;
           2011;5:423-6.&#xD;
&#xD;
       10. Yan YD, Woo JS, Kang JH, Yong CS, Choi HG. Preparation and evaluation of taste-masked&#xD;
           donepezil hydrochloride orally disintegrating tablets 1. Biol Pharm Bull&#xD;
           2010;33(8):1364-70.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Taste: 5-point likert scale</measure>
    <time_frame>Directly after consuming the fiber (1 minute)</time_frame>
    <description>= very poor taste / unpleasant&#xD;
= poor taste / unpleasant&#xD;
= neutral&#xD;
= tasty / pleasant&#xD;
= very tasty/ very pleasant</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Texture: 5-point likert scale</measure>
    <time_frame>Directly after consuming the fiber (1 minute)</time_frame>
    <description>= very poor taste / unpleasant&#xD;
= poor taste / unpleasant&#xD;
= neutral&#xD;
= tasty / pleasant&#xD;
= very tasty/ very pleasant</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Constipation</condition>
  <arm_group>
    <arm_group_label>Total group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Volcolon sugar free &amp; Metamucil Orange &amp; Psyllium Orange in a randomized order.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Volcolon sugar free</intervention_name>
    <description>1 sachet contains 4 g powder 980mg/g psyllium fibers x 4 g per sachet = 3.92 g psyllium fibers/sachet</description>
    <arm_group_label>Total group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metamucil Orange</intervention_name>
    <description>1 sachet contains 3.4 g psyllium fibers So 25 ml contains 0.425 g psyllium fibers</description>
    <arm_group_label>Total group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Psyllium Orange</intervention_name>
    <description>1 sachet contains 3.25 g psyllium fibers So 25 ml contains 0.406 g psyllium fibers</description>
    <arm_group_label>Total group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy volunteer&#xD;
&#xD;
          -  In good health&#xD;
&#xD;
          -  Able to understand the instruction and give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Gastrointestinal problems&#xD;
&#xD;
          -  Swallowing disorders&#xD;
&#xD;
          -  Rheumatic related diseases&#xD;
&#xD;
          -  Known hypersensitivity to the study medication&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richelle JF Felt-Bersma, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VU Medical Center Amsterdam</affiliation>
  </overall_official>
  <verification_date>November 2017</verification_date>
  <study_first_submitted>August 10, 2016</study_first_submitted>
  <study_first_submitted_qc>August 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2016</study_first_posted>
  <last_update_submitted>November 1, 2017</last_update_submitted>
  <last_update_submitted_qc>November 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>VU University Medical Center</investigator_affiliation>
    <investigator_full_name>PF Vollebregt</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Fibers</keyword>
  <keyword>Constipation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psyllium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

